Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: A novel tumorigenic pathway

Journal of Cellular Physiology

Volumn 209, Issue 1, 2006, Pages 44-55

  Pines, Alex ^a   Bivi, Nicoletta ^a   Vascotto, Carlo ^a   Romanello, Milena ^a   D'Ambrosio, Chiara ^b   Scaloni, Andrea ^b   Damante, Giuseppe ^a   Morisi, Roberta ^c   Filetti, Sebastiano ^c   Ferretti, Elisabetta ^c   Quadrifoglio, Franco ^a   Tell, Gianluca ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; CYCLIN D1; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOTIDE RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; RECEPTOR PROTEIN; REDOX EFFECTOR FACTOR 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THYROID CANCER; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION;

ADENOSINE TRIPHOSPHATE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DOWN-REGULATION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THYROID NEOPLASMS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 33748275679     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20704     Document Type: Article

References (54)

1. Abbracchio MP, Burnstock G. 1994. Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475.
2. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, Pestell RG. 1999. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274:34186-34195.
3. Bisca A, D'Ambrosio C, Scaloni A, Puglisi F, Aprile G, Piga A, Zuiani C, Bazzocchi M, Di Loreto C, Paron I, Tell G, Damante G. 2004. Proteomic evaluation of core biopsy specimens from breast lesions. Cancer Lett 204:79-86.
4. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
5. Bowler WB, Dixon CJ, Halleux C, Maier R, Bilbe G, Fraser WD, Gallagher JA, Hipskind RA. 1999. Signaling in human osteoblasts by extracellular nucleotides. Their weak induction of the c-fos proto-oncogene via Ca2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem 274:14315-14324.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, Ringel MD. 2004. 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J Clin Endocrinol Metab 89:2982-2988.
8. Burnstock G. 2002. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-373.
9. Burnstock G, Kennedy C. 1985. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-440.
10. Cano E, Mahadevan LC. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20:117-122.
11. Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani C, Di Virgilio F, Ferrannini E, Solini A. 2005. Extracellular adenosine 5′-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology 146:3172-3178.
12. Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, Fang WG. 2004. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett 215:239-247.
13. Coutinho-Silva R, Stahl L, Cheung KK, de Campos NE, de Oliveira Souza C, Ojcius DM, Burnstock G. 2005. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: Effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288:G1024-G1035.
14. Ekokoski E, Webb TE, Simon J, Tornquist K. 2001. Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells. J Cell Physiol 187:166-175.
15. Elia MG, Muscella A, Greco S, Vitella S, Storelli C, Marsigliante S. 2003. Disturbances in purinergic [Ca2+]i signaling pathways in a transformed rat thyroid cell line. Cell Calcium 33:59-68.
16. Erlinge D. 1998. Extracellular ATP: A growth factor for vascular smooth muscle cells. Gen Pharmacol 31:1-8.
17. Erlinge D, Heilig M, Edvinsson L. 1996. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells. Br J Pharmacol 118:1028-1034.
18. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. 1992. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 51:613-619.
19. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
20. Fung H, Demple B. 2005. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 17:463-470.
21. Greig AV, Linge C, Terenghi G, McGrouther DA, Burnstock G. 2003. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol 120:1007-1015.
22. He T, Weintraub NL, Goswami PC, Chatterjee P, Flaherty DM, Domann FE, Oberley LW. 2003. Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 285:H804-H812.
23. Hirai S, Izumi Y, Higa K, Kaibuchi K, Mizuno K, Osada S, Suzuki K, Ohno S. 1994. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J 13:2331-2340.
24. Hoebertz A, Arnett TR, Burnstock G. 2003. Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 24:290-297.
25. Huang N, Wang DJ, Heppel LA. 1989. Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. Proc Natl Acad Sci USA 86:7904-7908.
26. Izumi T, Brown DB, Naidu CV, Bhakat KK, Macinnes MA, Saito H, Chen DJ, Mitra S. 2005. Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci USA 102:5739-5743.
27. Jacques-Silva MC, Bernardi A, Rodnight R, Lenz G. 2004. ERK, PKC and PI3K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line. Oncology 67:450-459.
28. Kamal A, Boehm MF, Burrows FJ. 2004. Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 10:283-290.
29. Marsee DK, Venkateswaran A, Tao H, Vadysirisack D, Zhang Z, Vandre DD, Jhiang SM. 2004. Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. J Biol Chem 279:43990-43997.
30. Mittal V. 2004. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5:355-365.
31. Nakamura Y, Ohtaki S. 1990. Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cells. J Endocrinol 126:283-287.
32. Neary JT, Abbracchio MP. 2001. Trophic roles of purines and pyrimidines. In: Williams M, Abbracchio MP, editors. Handbook of experimental pharmacology: Purinergic and pyrimidergic signalling. New York: Springer, pp 305-338.
33. Novak I. 2003. ATP as a signaling molecule: The exocrine focus. News Physiol Sci 18:12-17.
34. Ostrom RS, Gregorian C, Insel PA. 2000. Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem 275:11735-11739.
35. Park JW, Yeh MW, Wong MG, Lobo M, Hyun WC, Duh QY, Clark OH. 2003. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. J Clin Endocrinol Metab 88:3346-3353.
36. Paron I, D'Ambrosio C, Scaloni A, Berlingieri MT, Pallante PL, Fusco A, Bivi N, Tell G, Damante G. 2005. A differential proteomic approach to identify proteins associated with thyroid cell transformation. J Mol Endocrinol 34:199-207.
37. Pines A, Romanello M, Cesaratto L, Damante G, Moro L, D'Andrea P, Tell G. 2003. Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line. Biochem J 373:815-824.
38. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gulisano M, Kelley MR, Quadrifoglio F, Tell G. 2005. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33:4379-4394.
39. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R. 1999. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 276:H1468-H1481.
40. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
41. Risso A, Tell G, Vascotto C, Costessi A, Arena S, Scaloni A, Cosulich ME. 2005. Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: A proteomics study. Proteomics 5:1827-1837.
42. Romanello M, Pani B, Bicego M, D'Andrea P. 2001. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289:1275-1281.
43. Sauer H, Klimm B, Hescheler J, Wartenberg M. 2001. Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. FASEB J 15:2539-2541.
44. Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136.
45. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858.
46. Tell G, Damante G, Caldwell D, Kelley MR. 2005. The intracellular localization of APE1/Ref-1: More than a passive phenomenon? Antioxid Redox Signal 7:367-384.
47. Thevananther S, Sun H, Li D, Arjunan V, Awad SS, Wyllie S, Zimmerman TL, Goss JA, Karpen SJ. 2004. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39: 393-402.
48. Tornquist K, Ekokoski E, Dugue B. 1996. Purinergic agonist ATP is a comitogen in thyroid FRTL-5 cells. J Cell Physiol 166:241-248.
49. Tu MT, Luo SF, Wang CC, Chien CS, Chiu CT, Lin CC, Yang CM. 2000. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 129:1481-1489.
50. Van Sande J, Dumont JE, Melander A, Sundler F. 1980. Presence and influence of cholinergic nerves in the human thyroid. J Clin Endocrinol Metab 51:500-502.
51. Vertegaal AC, Kuiperij HB, Yamaoka S, Courtois G, van der Eb AJ, Zantema A. 2000. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells. Cell Signal 12:759-768.
52. White N, Ryten M, Clayton E, Butler P, Burnstock G. 2005. P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 224:81-91.
53. Yano M, Naito Z, Yokoyama M, Shiraki Y, Ishiwata T, Inokuchi M, Asano G. 1999. Expression of hsp90 and cyclin D1 in human breast cancer. Cancer Lett 137:45-51.
54. Zhang W, Chait BT. 2000. ProFound: An expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 72:2482-2489.